Lung cancer is the leading cause of cancer-related mortality worldwide, largely due to late-stage diagnosis. Low-dose computed tomography (LDCT) screening has emerged as a powerful tool for early detection, enabling diagnosis at curable stages and reducing lung cancer mortality. Despite strong evidence, LDCT screening uptake remains suboptimal globally. This review synthesizes current evidence supporting LDCT screening, highlights ongoing global implementation efforts, and discusses key insights from the 1st AGILE conference. Lung cancer screening is gaining global momentum, with many countries advancing plans for national LDCT programs. Expanding eligibility through risk-based models and targeting high-risk never- and light-smokers are emerging strategies to improve efficiency and equity. Technological advancements, including AI-assisted interpretation and image-based biomarkers, are addressing concerns around false positives, overdiagnosis, and workforce burden. Integrating cardiac and smoking-related disease assessment within LDCT screening offers added preventive health benefits. To maximize global impact, screening strategies must be tailored to local health systems and populations. Efforts should focus on increasing awareness, standardizing protocols, optimizing screening intervals, and strengthening multidisciplinary care pathways. International collaboration and shared infrastructure can accelerate progress and ensure sustainability. LDCT screening represents a cost-effective opportunity to reduce lung cancer mortality and premature deaths.

Chest X-ray is one of the main diagnostic tools in emergency medicine, yet its limited ability to capture fine anatomical details can result in missed or delayed diagnoses. To address this, we introduce XVertNet, a novel deep-learning framework designed to enhance vertebral structure visualization in X-ray images significantly. Our framework introduces two key innovations: (1) an unsupervised learning architecture that eliminates reliance on manually labeled training data-a persistent bottleneck in medical imaging, and (2) a dynamic self-tuned internal guidance mechanism featuring an adaptive feedback loop for real-time image optimization. Extensive validation across four major public datasets revealed that XVertNet outperforms state-of-the-art enhancement methods, as demonstrated by improvements in evaluation measures such as entropy, the Tenengrad criterion, LPC-SI, TMQI, and PIQE. Furthermore, clinical validation conducted by two board-certified clinicians confirmed that the enhanced images enabled more sensitive examination of vertebral structural changes. The unsupervised nature of XVertNet facilitates immediate clinical deployment without requiring additional training overhead. This innovation represents a transformative advancement in emergency radiology, providing a scalable and time-efficient solution to enhance diagnostic accuracy in high-pressure clinical environments.

A chest X-ray radiology report describes abnormal findings not only from X-ray obtained at a given examination, but also findings on disease progression or change in device placement with reference to the X-ray from previous examination. Majority of the efforts on automatic generation of radiology report pertain to reporting the former, but not the latter, type of findings. To the best of the authors' knowledge, there is only one work dedicated to generating summary of the latter findings, i.e., follow-up radiology report summary. In this study, we propose a transformer-based framework to tackle this task. Motivated by our observations on the significance of medical lexicon on the fidelity of report summary generation, we introduce two mechanisms to bestow clinical insight to our model, namely disease probability soft guidance and masked entity modeling loss. The former mechanism employs a pretrained abnormality classifier to guide the presence level of specific abnormalities, while the latter directs the model's attention toward medical lexicon. Extensive experiments were conducted to demonstrate that the performance of our model exceeded the state-of-the-art.

In data-scarce scenarios, deep learning models often overfit to noise and irrelevant patterns, which limits their ability to generalize to unseen samples. To address these challenges in medical image segmentation, we introduce Diff-UMamba, a novel architecture that combines the UNet framework with the mamba mechanism for modeling long-range dependencies. At the heart of Diff-UMamba is a Noise Reduction Module (NRM), which employs a signal differencing strategy to suppress noisy or irrelevant activations within the encoder. This encourages the model to filter out spurious features and enhance task-relevant representations, thereby improving its focus on clinically meaningful regions. As a result, the architecture achieves improved segmentation accuracy and robustness, particularly in low-data settings. Diff-UMamba is evaluated on multiple public datasets, including MSD (lung and pancreas) and AIIB23, demonstrating consistent performance gains of 1-3% over baseline methods across diverse segmentation tasks. To further assess performance under limited-data conditions, additional experiments are conducted on the BraTS-21 dataset by varying the proportion of available training samples. The approach is also validated on a small internal non-small cell lung cancer (NSCLC) dataset for gross tumor volume (GTV) segmentation in cone beam CT (CBCT), where it achieves a 4-5% improvement over the baseline.

Pulmonary diseases have become one of the main reasons for people's health decline, impacting millions of people worldwide. Rapid advancement of deep learning has significantly impacted medical image analysis by improving diagnostic accuracy and efficiency. Timely and precise diagnosis of these diseases proves to be invaluable for effective treatment procedures. Chest X-rays (CXR) perform a pivotal role in diagnosing various respiratory diseases by offering valuable insights into the chest and lung regions. This study puts forth a hybrid approach for classifying CXR images into four classes namely COVID-19, tuberculosis, pneumonia, and normal (healthy) cases. The presented method integrates a machine learning method, Support Vector Machine (SVM), with a pre-trained deep learning model for improved classification accuracy and reduced training time. Data from a number of public sources was used in this study, which represents a wide range of demographics. Class weights were implemented during training to balance the contribution of each class in order to address the class imbalance. Several pre-trained architectures, namely DenseNet, MobileNet, EfficientNetB0, and EfficientNetB3, have been investigated, and their performance was evaluated. Since MobileNet achieved the best classification accuracy of 94%, it was opted for the hybrid model, which combines MobileNet with SVM classifier, increasing the accuracy to 97%. The results suggest that this approach is reliable and holds great promise for clinical applications.&#xD.

Limited patient data availability presents a challenge for efficient machine learning (ML) model development. Recent studies have proposed methods to generate synthetic medical images but lack the corresponding prognostic information required for predicting outcomes. We present a cancer outcomes modelling approach that involves generating a comprehensive synthetic dataset which can accurately mimic a real dataset. A real public dataset containing computed tomography-based radiomic features and clinical information for 132 non-small cell lung cancer patients was used. A synthetic dataset of virtual patients was synthesized using a conditional tabular generative adversarial network. Models to predict two-year overall survival were trained on real or synthetic data using combinations of four feature selection methods (mutual information, ANOVA F-test, recursive feature elimination, random forest (RF) importance weights) and six ML algorithms (RF, k-nearest neighbours, logistic regression, support vector machine, XGBoost, Gaussian Naïve Bayes). Models were tested on withheld real data and externally validated. Real and synthetic datasets were similar, with an average one minus Kolmogorov-Smirnov test statistic of 0.871 for continuous features. Chi-square test confirmed agreement for discrete features (p < 0.001). XGBoost using RF importance-based features performed the most consistently for both datasets, with percent differences in balanced accuracy and area under the precision-recall curve of < 1.3%. Preliminary findings demonstrate the potential application of synthetic radiomic and clinical data augmentation for cancer outcomes modelling, although further validation with larger diverse datasets is crucial. While our approach was described in a lung context, it may be applied to other sites or endpoints.

In data-scarce scenarios, deep learning models often overfit to noise and irrelevant patterns, which limits their ability to generalize to unseen samples. To address these challenges in medical image segmentation, we introduce Diff-UMamba, a novel architecture that combines the UNet framework with the mamba mechanism to model long-range dependencies. At the heart of Diff-UMamba is a noise reduction module, which employs a signal differencing strategy to suppress noisy or irrelevant activations within the encoder. This encourages the model to filter out spurious features and enhance task-relevant representations, thereby improving its focus on clinically significant regions. As a result, the architecture achieves improved segmentation accuracy and robustness, particularly in low-data settings. Diff-UMamba is evaluated on multiple public datasets, including medical segmentation decathalon dataset (lung and pancreas) and AIIB23, demonstrating consistent performance gains of 1-3% over baseline methods in various segmentation tasks. To further assess performance under limited data conditions, additional experiments are conducted on the BraTS-21 dataset by varying the proportion of available training samples. The approach is also validated on a small internal non-small cell lung cancer dataset for the segmentation of gross tumor volume in cone beam CT, where it achieves a 4-5% improvement over baseline.

Visceral pleural invasion (VPI) indicates poor prognosis in non-small cell lung cancer (NSCLC), and upgrades T classification of NSCLC from T1 to T2 when accompanied by VPI. This study aimed to develop and validate deep learning models for the accurate prediction of VPI in patients with NSCLC, and to compare the performance of two-dimensional (2D), three-dimensional (3D), and hybrid 3D models. This retrospective study included consecutive patients with pathologically confirmed lung tumor between June 2017 and September 2022. The clinical data and preoperative imaging features of these patients were investigated and their relationships with VPI were statistically compared. Elastic fiber staining analysis results were the gold standard for diagnosis of VPI. The data of non-VPI and VPI patients were randomly divided into training cohort and validation cohort based on 8:2 and 6:4, respectively. The EfficientNet-B0_2D model and Double-head Res2Net/_F6/_F24 models were constructed, optimized and verified using two convolutional neural network model architectures-EfficientNet-B0 and Res2Net, respectively, by extracting the features of original CT images and combining specific clinical-CT features. The receiver operating characteristic curve, the area under the curve (AUC), and confusion matrix were utilized to assess the diagnostic efficiency of models. Delong test was used to compare performance between models. A total of 1931 patients with NSCLC were finally evaluated. By univariate analysis, 20 clinical-CT features were identified as risk predictors of VPI. Comparison of the diagnostic efficacy among the EfficientNet-b0_2D, Double-head Res2Net, Res2Net_F6, and Res2Net_F24 combined models revealed that Double-head Res2Net_F6 model owned the largest AUC of 0.941 among all models, followed by Double-head Res2Net (AUC=0.879), Double-head Res2Net_F24 (AUC=0.876), and EfficientNet-b0_2D (AUC=0.785). The three 3D-based models showed comparable predictive performance in the validation cohort and all outperformed the 2D model (EfficientNet-B0_2D, all P＜0.05). It is feasible to predict VPI in NSCLC with the predictive models based on deep learning, and the Double-head Res2Net_F6 model fused with six clinical-CT features showed greatest diagnostic efficacy.

The integration of artificial intelligence (AI) into medical image analysis has transformed healthcare, offering unprecedented precision in diagnosis, treatment planning, and disease monitoring. However, its adoption within the Internet of Medical Things (IoMT) raises significant challenges related to transparency, trustworthiness, and security. This paper introduces a novel Explainable AI (XAI) framework tailored for Medical Cyber-Physical Systems (MCPS), addressing these challenges by combining deep neural networks with symbolic knowledge reasoning to deliver clinically interpretable insights. The framework incorporates an Enhanced Dynamic Confidence-Weighted Attention (Enhanced DCWA) mechanism, which improves interpretability and robustness by dynamically refining attention maps through adaptive normalization and multi-level confidence weighting. Additionally, a Resilient Observability and Detection Engine (RODE) leverages sparse observability principles to detect and mitigate adversarial threats, ensuring reliable performance in dynamic IoMT environments. Evaluations conducted on benchmark datasets, including CheXpert, RSNA Pneumonia Detection Challenge, and NIH Chest X-ray Dataset, demonstrate significant advancements in classification accuracy, adversarial robustness, and explainability. The framework achieves a 15% increase in lesion classification accuracy, a 30% reduction in robustness loss, and a 20% improvement in the Explainability Index compared to state-of-the-art methods.

Detecting Pulmonary Embolism (PE) is critical for effective patient care, and Artificial Intelligence (AI) has shown promise in supporting radiologists in this task. Integrating AI into radiology workflows requires not only evaluation of its diagnostic accuracy but also assessment of its acceptance among clinical staff. This study aims to evaluate the performance of an AI algorithm in detecting pulmonary embolisms (PEs) on contrast-enhanced computed tomography pulmonary angiograms (CTPAs) and to assess the level of acceptance of the algorithm among radiology department staff. This retrospective study analyzed anonymized computed tomography pulmonary angiography (CTPA) data from a university clinic. Surveys were conducted at three and nine months after the implementation of a commercially available AI algorithm designed to flag CTPA scans with suspected PE. A thoracic radiologist and a cardiac radiologist served as the reference standard for evaluating the performance of the algorithm. The AI analyzed 59 CTPA cases during the initial evaluation and 46 cases in the follow-up assessment. In the first evaluation, the AI algorithm demonstrated a sensitivity of 84.6% and a specificity of 94.3%. By the second evaluation, its performance had improved, achieving a sensitivity of 90.9% and a specificity of 96.7%. Radiologists' acceptance of the AI tool increased over time. Nevertheless, despite this growing acceptance, many radiologists expressed a preference for hiring an additional physician over adopting the AI solution if the costs were comparable. Our study demonstrated high sensitivity and specificity of the AI algorithm, with improved performance over time and a reduced rate of unanalyzed scans. These improvements likely reflect both algorithmic refinement and better data integration. Departmental feedback indicated growing user confidence and trust in the tool. However, many radiologists continued to prefer the addition of a resident over reliance on the algorithm. Overall, the AI showed promise as a supportive "second-look" tool in emergency radiology settings. The AI algorithm demonstrated diagnostic performance comparable to that reported in similar studies for detecting PE on CTPA, with both sensitivity and specificity showing improvement over time. Radiologists' acceptance of the algorithm increased throughout the study period, underscoring its potential as a complementary tool to physician expertise in clinical practice.